Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Botulinum Toxin For Essential Tremor Of The Voice With Multiple Anatomical Sites Of Tremor: A Crossover Design Study Of Unilateral Versus Bilateral Injection

P. Warrick, C. Dromey, J. Irish, L. Durkin, A. Pakiam, A. Lang
Published 2000 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Objectives/Hypothesis To evaluate the relative efficacy of unilateral and bilateral injections of botulinum toxin injection (BOTOX) in the treatment of essential tremor of the voice (ETV).
This paper references
10.1001/ARCHOTOL.1988.01860240057024
Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum)
A. W. Biglan (1988)
Essential tremor: clinical correlates in 350 patients
Lou J-S (1991)
10.1177/000348949810700403
Unilateral versus Bilateral Botulinum Toxin Injections in Adductor Spasmodic Dysphonia
T. Langeveld (1998)
10.1017/S0317167100020254
The nature of primary vocal tremor.
V. Hachinski (1975)
10.1002/ANA.410170404
Association between essential tremor and Parkinson's disease
J. J. Geraghty (1985)
10.1212/WNL.41.8.1185
Botulinum toxin treatment of tremors
J. Jankovic (1991)
10.1177/019459989210700510
An Evaluation of Laryngeal Muscle Activation in Patients with Voice Tremor
J. Koda (1992)
Head, facial, and voice tremor.
L. Findley (1988)
Is there a relationship between Parkinson’s disease and essential tremor? Clin Neuropharmacol 1993;16:30–35
R Pahwa (1993)
Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
S. G. Adams (1993)
10.3109/9780203450321-49
Therapy with botulinum toxin
J. Jankovic (1994)
The evaluation and management of abductor laryngeal dystonia
A Blitzer (1994)
A comparison of bilateral and unilateral botulinum toxin treatments for botulinum toxin treatments for spasmodic dysphonia
P Zwirner (1993)
Responses of stutterers and vocal tremor patients to treatment with botulinum toxin
SV Stager (1994)
Treatment of voice tremor with botulinum toxin injection
C L Ludlow (1989)
Botulinum toxin injection for adductor spasmodic dysphonia
CL Ludlow (1994)
Oromandibular dystonia: Treatment of 96 patients with botulinum toxin A
M. Brin (1994)
10.1016/0022-510X(93)90047-3
Glucose metabolism in the brain of patients with essential tremor
M. Hallett (1993)
10.1001/ARCHNEUR.1986.00520040060020
Botulinum toxin in the management of blepharospasm.
J. Dutton (1986)
10.1097/00005537-199603000-00010
Effects of Botulinum Toxin Type A Injections on Aerodynamic Measures of Spasmodic Dysphonia
S. Adams (1996)
Limb dystonia: treatment with botulinum toxin
S. Pullman (1994)
10.1002/MDS.870090602
Factors influencing the amplitude and frequency of essential tremor
R. Elble (1994)
Treatment of voice tremor with botulinum toxin injection [abstract
CL Ludlow (2000)
10.1097/00002826-199302000-00003
Is there a relationship between Parkinson's disease and essential tremor?
R. Pahwa (1993)
Head, facial, and voice tremor.
Findley Lj (1988)
10.1007/978-1-349-06757-2
Movement Disorders: Tremor
L. Findley (1984)
Essential voice tremor: treatment with propranolol
W Koller (1985)
10.1016/S0163-7258(96)00091-5
Botulinum toxin as a therapeutic agent.
J. Tsui (1996)
Essential Vocal Tremor: Clinical Characteristics and Response to Therapy
E. Massey (1985)
10.1044/JSHR.3503.562
Vocal tremor analysis with the Vocal Demodulator.
W. S. Winholtz (1992)
10.1212/WNL.47.5.1331
Methazolamide for essential voice tremor
K. Busenbark (1996)
10.1212/WNL.41.2_Part_1.234
Essential tremor
J. S. Lou (1991)
10.1044/JSHD.4602.138
A clinical method for estimating laryngeal airway resistance during vowel production.
J. R. Smitheran (1981)
10.1002/ANA.410340115
A positron emission tomography study of essential tremor: Evidence for overactivity of cerebellar connections
I. Jenkins (1993)
Botulinum toxin A for cranial-cervical dystonia: a double blind placebo controlled study
J Jankovic (1987)
10.1212/wnl.13.6.520
Organic voice tremor. A tremor of phonation.
J. R. Brown (1963)
10.1113/jphysiol.1986.sp016147
Oscillatory properties of guinea‐pig inferior olivary neurones and their pharmacological modulation: an in vitro study.
R. Llinás (1986)
How familial is familial tremor? The genetic epidemiology of essential tremor
ED Louis (1996)
10.1001/ARCHOTOL.1984.00800320048011
Spastic dysphonia and essential (voice) tremor treated with primidone.
D. E. Hartman (1984)
10.1212/WNL.37.4.616
Botulinum A toxin for cranial‐cervical dystonia
J. Jankovic (1987)
Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
S. Adams (1995)
10.1288/00005537-199106000-00010
Double‐blind controlled study of botulinum toxin in adductor spasmodic dysphonia
Daniel D. Truong (1991)
10.1002/ANA.410350613
The relationship of essential tremor to other movement disorders: Report on 678 patients
W. Koller (1994)
10.1007/978-1-349-06757-2_14
Epidemiology of essential tremor
I. Rautakorpi (1984)
10.1212/WNL.35.1.108
Long‐acting propranolol in essential tremor
W. Koller (1985)
10.1136/jnnp.29.3.219
Dysphonia due to tremor.
G. Ardran (1966)
10.1016/S0025-6196(12)61721-2
Treatment of essential tremor with methazolamide.
M. Muenter (1991)



This paper is referenced by
10.1016/B978-012738903-5/50008-4
Botulinum Toxins: Transformation of a Toxin into a Treatment
Cynthia L. Cornelia (2005)
10.1016/S0002-9343(03)00259-6
Essential tremor: differential diagnosis and current therapy.
R. Pahwa (2003)
Voice tremor in Parkinson's disease (PD) :identification, characterisation and relationship with speech, voice and disease variables
P. Gillivan-Murphy (2013)
10.2165/11316050-000000000-00000
Epidemiology and Management of Essential Tremor in Children
J. Ferrara (2009)
10.1007/978-3-030-28852-5
Neurologic and Neurodegenerative Diseases of the Larynx
P. Weissbrod (2020)
10.1007/978-3-030-50691-9
Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine
B. Jabbari (2020)
Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials
F. Irccs (2015)
10.1007/978-3-662-46780-0_8
Rehabilitation and Prognosis of Voice Disorders
S. Akbulut (2020)
10.1097/01.nrl.0000138736.07840.b2
Essential Tremor: Epidemiology, Diagnosis, and Treatment
K. Sullivan (2004)
10.1016/j.parkreldis.2019.01.023
Botulinum toxin for the treatment of tremor.
S. Mittal (2019)
Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
A. Blitzer (2008)
10.1007/s00415-012-6750-9
Erratum to: Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association
M. Zappia (2012)
10.1592/phco.23.10.1105.32750
Essential Tremor: Diagnosis and Treatment
J. J. Chen (2003)
conditions An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck
Ricardo Persaud (2013)
10.1121/1.4967454
The effects of physiological adjustments on the perceptual and acoustical characteristics of vibrato as a model of vocal tremor.
Rosemary A. Lester-Smith (2016)
10.1016/B978-1-4160-6641-5.00029-5
Essential Tremor and Other Tremors
G. Deuschl (2010)
10.1002/9781444346183.CH6
6. Essential Tremor
J. Benito-León (2012)
10.1007/978-3-319-14598-3_5
Treatment of Essential Tremor
A. Rana (2015)
Audio-visual analysis of vocal tremor derived from acoustics, laryngovideostroboscopy & HSDI
Julie M Barkmeier-Kraemer (2016)
10.1159/000495413
Unilateral Thalamic Deep Brain Stimulation for Voice Tremor
J. Avecillas-Chasin (2018)
10.1007/978-3-030-28852-5_25
Laryngeal and Extralaryngeal Botulinum Toxin Injections
William Z. Gao (2020)
10.4140/TCP.N.2008.364
Essential tremor: symptoms and treatment.
J. Wick (2008)
10.1212/01.wnl.0000311389.26145.95
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review)
D. Simpson (2008)
10.1016/S1567-4231(09)70189-3
Chapter 41 Focal injection therapy
Jean-Michel Gracies (2003)
10.3390/toxins9110356
Chemodenervation of the Larynx
Rachel Kaye (2017)
Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Peter James Dyck (2003)
10.1007/978-3-642-23499-6_513
Larynx, Neurological Disorders
J. Achkar (2013)
10.1001/jamaoto.2015.2849
Primidone Therapy for Essential Vocal Tremor.
Andrew Nida (2016)
10.1016/j.otohns.2009.01.026
Recommendations of the Neurolaryngology Study Group on laryngeal electromyography
A. Blitzer (2009)
10.1016/S1047-9651(03)00046-9
Botulinum toxin for spasmodic dysphonia.
A. Rodriquez (2003)
10.1044/VVD14.1.6
Documenting Outcomes in Vocal Tremor
C. Dromey (2004)
10.34160/JKDS.2015.5.1.002
Botulinum Toxin for Upper Esophageal Sphincter and Larynx
Sangmin Lee (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar